Genotyping of 21 mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 genes was performed for 102 BOT patients, 167 cases of ovarian cancer G1, and 1743 healthy controls. The gene discussed is BRCA1; the disease is ovarian carcinoma.